Scilex Holding Company (“Scilex”) announced that its board of directors has approved the distribution of Semnur Pharmaceuticals, Inc. common stock as dividends to holders of Scilex common stock and other eligible securities.

```htmlThe record date for the dividend has been set for June 1, 2026. This resolution marks a key advancement in the company’s capital allocation strategy. By distributing shares of Semnur Pharmaceuticals, Scilex aims to directly reward its shareholders, while potentially strengthening the strategic ties between the two entities. The range of holders eligible for this stock dividend includes holders of Scilex common shares and other designated equity securities.The company is expected to provide further detailed operational information closer to the distribution date. Shareholders should pay attention to upcoming announcements for important details regarding the ex-dividend date, distribution ratio, and specific procedures. This action reflects the Scilex board’s commitment to enhancing shareholder value and exploring innovative ways of delivering returns.```